Literature DB >> 7889542

Technetium-99m-labeled antibodies. Stability compared to 125I labeled antibodies.

C S Gooden1, D E Snook, A A Epenetos.   

Abstract

It is essential in any method for radiolabeling antibody with 99mTc that the labeling procedure is rapid and reliable, producing a highly stable 99mTc-antibody complex with minimal effect on the immunoreactivity of the antibody. In the present study, analysis of the stability and homogeneity of radiolabeled (99mTc and 125I) antibodies (HMFG1 and PR1A3) was carried out by fast protein liquid chromatography (FPLC) using superose-6 and S-200 columns, and by polyacrylamide gel electrophoresis (PAGE) followed by autoradiography. Superose 6 and S-200 gel filtration analysis showed the radiolabel (99mTc or 125I) eluting with a retention time identical to that of native antibody. No peaks of relative molecular size (Mr) corresponding to possible antibody fragments were seen in either the UV or the radioactive FPLC elution profiles. PAGE analysis of 99mTc labeled antibody, however, revealed the presence of a number of radiolabeled antibody fragments (Mr < IgG) that were not detected by the same analysis of 125I labeled antibody. The stability of the radiolabeled antibodies in serum in vitro was also studied. FPLC (superose-6) analysis after 45 h incubation in normal serum in vitro revealed 3.3% (HMFG1), and 20% (PR1A3) of the 99mTc on a molecule or aggregate with a Mr greater than that of IgG. There is also the appearance of small amounts of 99mTc-labeled material with a Mr < IgG in the later fractions (2.2% for HMFG1 and 4.9% for PR1A3). Similar results were obtained using radioiodinated antibody, although the small amount of low molecular size material detected as a single peak with a longer retention time than the 99mTc equivalent corresponds to free iodide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7889542     DOI: 10.1007/bf03033866

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  14 in total

1.  99mTc radioimmunoscintigraphy of colorectal cancer.

Authors:  M Granowska; S J Mather; K E Britton; S Bentley; P Richman; R K Phillips; J M Northover
Journal:  Br J Cancer Suppl       Date:  1990-07

2.  The labeling of high affinity sites of antibodies with 99mTc.

Authors:  C H Paik; L N Phan; J J Hong; M S Sahami; S C Heald; R C Reba; J Steigman; W C Eckelman
Journal:  Int J Nucl Med Biol       Date:  1985

3.  Reduction-mediated technetium-99m labeling of monoclonal antibodies.

Authors:  S J Mather; D Ellison
Journal:  J Nucl Med       Date:  1990-05       Impact factor: 10.057

4.  Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m.

Authors:  R L Childs; D J Hnatowich
Journal:  J Nucl Med       Date:  1985-03       Impact factor: 10.057

5.  Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.

Authors:  J Taylor-Papadimitriou; J A Peterson; J Arklie; J Burchell; R L Ceriani; W F Bodmer
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

6.  Formation of 99mTc-immunoglobulin G complexes free from radiocolloids, quality controlled by radioimmunoelectrophoresis.

Authors:  E Sundrehagen
Journal:  Eur J Nucl Med       Date:  1982

7.  Synthesis and preliminary evaluation of a new chelate N2S4 for use in labeling proteins with metallic radionuclides.

Authors:  A Najafi; M M Alauddin; M E Siegel; A L Epstein
Journal:  Int J Rad Appl Instrum B       Date:  1991

8.  Technetium-99m labeled monoclonal antibodies: evaluation of reducing agents.

Authors:  M L Thakur; J DeFulvio; M D Richard; C H Park
Journal:  Int J Rad Appl Instrum B       Date:  1991

9.  Synthesis and evaluation of a new bifunctional chelating agent for 99mTc labeling proteins: p-carboxyethylphenylglyoxal-di(N-methylthiosemicarbazone).

Authors:  Y Arano; A Yokoyama; Y Magata; H Saji; K Horiuchi; K Torizuka
Journal:  Int J Nucl Med Biol       Date:  1986

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.